BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1334053)

  • 1. Quantitation of biological tumor markers (p53, c-myc, Ki-67 and DNA ploidy) by multiparameter flow cytometry in non-small-cell lung cancer.
    Mørkve O; Halvorsen OJ; Stangeland L; Gulsvik A; Laerum OD
    Int J Cancer; 1992 Dec; 52(6):851-5. PubMed ID: 1334053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [DNA content analysis and detection of c-myc and p53 products using flow cytometry in resected lung cancer cases].
    Chiba W; Sawai S; Ikeda S; Morimoto K; Wazawa H; Hanawa T; Yamashita N; Matsui T; Hatakenaka R; Matsubara Y
    Gan To Kagaku Ryoho; 1994 May; 21 Suppl 1():108-16. PubMed ID: 8203922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA ploidy and MYC DNA amplification in ovarian carcinomas. Correlation with p53 and bcl-2 expression, proliferative activity and prognosis.
    Diebold J; Suchy B; Baretton GB; Blasenbreu S; Meier W; Schmidt M; Rabes H; Löhrs U
    Virchows Arch; 1996 Nov; 429(4-5):221-7. PubMed ID: 8972757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 expression in non small cell lung cancer: clinical and biological correlations.
    Fontanini G; Bigini D; Vignati S; Macchiarini P; Pepe S; Angeletti CA; Pingitore R; Squartini F
    Anticancer Res; 1993; 13(3):737-42. PubMed ID: 8100413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of biological parameters on fine-needle aspirates from non-small cell lung cancer.
    Bozzetti C; Guazzi A; Nizzoli R; Naldi N; Franciosi V; Cascinu S
    Methods Mol Med; 2003; 75():405-20. PubMed ID: 12407756
    [No Abstract]   [Full Text] [Related]  

  • 6. Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the Perugia Multidisciplinary Team for Thoracic Tumors.
    Ludovini V; Pistola L; Gregorc V; Floriani I; Rulli E; Di Carlo L; Semeraro A; Daddi G; Darwish S; Stocchi L; Tofanetti FR; Bellezza G; Sidoni A; Tognellini R; Crinò L; Tonato M
    Tumori; 2008; 94(3):398-405. PubMed ID: 18705409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of p53 protein expression and DNA ploidy in surgically treated non-small cell lung carcinomas.
    Mørkve O; Halvorsen OJ; Skjaerven R; Stangeland L; Gulsvik A; Laerum OD
    Anticancer Res; 1993; 13(3):571-8. PubMed ID: 8391242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appraisal of intratumoral microvessel density, MIB-1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma.
    Gelb AB; Sudilovsky D; Wu CD; Weiss LM; Medeiros LJ
    Cancer; 1997 Nov; 80(9):1768-75. PubMed ID: 9351546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoform expression of CD44 adhesion molecules, Bcl-2, p53 and Ki-67 proteins in lung cancer.
    Mizera-Nyczak E; Dyszkiewicz W; Heider KH; Zeromski J
    Tumour Biol; 2001; 22(1):45-53. PubMed ID: 11054026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations.
    Volm M; Efferth T; Mattern J
    Anticancer Res; 1992; 12(1):11-20. PubMed ID: 1348920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P53 expression, DNA ploidy and S-phase cell fraction in operable locally advanced non-small-cell lung cancer.
    Costa A; Silvestrini R; Mochen C; Lequaglie C; Boracchi P; Faranda A; Vessecchia G; Ravasi G
    Br J Cancer; 1996 Apr; 73(7):914-9. PubMed ID: 8611406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low levels of p27 in association with deregulated p53-pRb protein status enhance tumor proliferation and chromosomal instability in non-small cell lung carcinomas.
    Tsoli E; Gorgoulis VG; Zacharatos P; Kotsinas A; Mariatos G; Kastrinakis NG; Kokotas S; Kanavaros P; Asimacopoulos P; Bramis J; Kletsas D; Papavassiliou AG; Kittas C
    Mol Med; 2001 Jun; 7(6):418-29. PubMed ID: 11474135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferating cell nuclear antigen and Ki-67 in lung carcinoma. Correlation with DNA flow cytometric analysis.
    Kawai T; Suzuki M; Kono S; Shinomiya N; Rokutanda M; Takagi K; Ogata T; Tamai S
    Cancer; 1994 Nov; 74(9):2468-75. PubMed ID: 7923002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inverted urothelial papilloma: is ploidy, MIB-1 proliferative activity, or p53 protein accumulation predictive of urothelial carcinoma?
    Cheville JC; Wu K; Sebo TJ; Cheng L; Riehle D; Lohse CM; Shane V
    Cancer; 2000 Feb; 88(3):632-6. PubMed ID: 10649258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA ploidy, proliferation, and neu-oncogene protein overexpression in breast carcinoma.
    Lee AK; Wiley B; Loda M; Bosari S; Dugan JM; Hamilton W; Heatley GJ; Cook L; Silverman ML
    Mod Pathol; 1992 Jan; 5(1):61-7. PubMed ID: 1347424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Useful prognostic panel markers to express the biological tumor status in resected lung adenocarcinomas.
    Carvalho PE; Antonãngelo L; Bernardi FD; Leão LE; Rodrigues OR; Capelozzi VL
    Jpn J Clin Oncol; 2000 Nov; 30(11):478-86. PubMed ID: 11155917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of the proliferation index in surgically resected non-small-cell lung cancer.
    Pence JC; Kerns BJ; Dodge RK; Iglehart JD
    Arch Surg; 1993 Dec; 128(12):1382-90. PubMed ID: 8250713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.
    Blom R; Guerrieri C; Stâl O; Malmström H; Simonsen E
    Gynecol Oncol; 1998 Jan; 68(1):54-61. PubMed ID: 9454661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deregulated expression of c-mos in non-small cell lung carcinomas: relationship with p53 status, genomic instability, and tumor kinetics.
    Gorgoulis VG; Zacharatos P; Mariatos G; Liloglou T; Kokotas S; Kastrinakis N; Kotsinas A; Athanasiou A; Foukas P; Zoumpourlis V; Kletsas D; Ikonomopoulos J; Asimacopoulos PJ; Kittas C; Field JK
    Cancer Res; 2001 Jan; 61(2):538-49. PubMed ID: 11212247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant mixed Müllerian tumors of the uterus: a clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 44 cases.
    Blom R; Guerrieri C; Stâl O; Malmström H; Sullivan S; Simonsen E
    Gynecol Oncol; 1998 Jan; 68(1):18-24. PubMed ID: 9454654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.